Home › Research › Topics › phosphorylated-tau217
phosphorylated-tau217
2 studies tagged phosphorylated-tau217, dated 2024-12-23 to 2025-03-06. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis 2025-03-06
- Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis 2024-12-23
Studies
2 studies carry this tag.
Date range
2024 to 2025
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Journal of neurology 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
These results confirm that blood-based pTau217 is a reliable marker of amyloid pathology with significant implications for clinical practice in the AD continuum.
-
Our review summarizes the diagnostic accuracy of plasma and cerebrospinal fluid (CSF) phosphorylated tau 217 (p-tau217) in detecting amyloid and tau pathology on positron emission tomography (PET).